Background and Purpose-Cerebrovascular reserve (CVR) by both transcranial Doppler ultrasonography (TCD) and quantitative cerebral blood flow (CBF) can identify subgroups of patients at increased risk for stroke. A direct comparison of CVR measurements obtained with both technologies in patients with cerebrovascular occlusive disease is lacking. Methods-CVRs before and after acetazolamide administration (1 g IV) were measured by TCD insonation of the middle cerebral artery (MCA) and CBF obtained with stable xenon CT (Xe/CT) in 38 patients with carotid occlusive disease. Sensitivity/specificity calculations were based on 2 Xe/CT MCA values: an average over 4 levels and the level with the lowest percent change in CBF. Compromised CVR was defined as no reactivity or a decrease in reactivity. Results-Using the analysis of the systolic TCD, we found that velocity changes compared with the average Xe/CT MCA CVR showed a sensitivity of 33%, specificity of 90.6%, positive predictive value of 54.5%, and negative predictive value of 80%. The sensitivity of TCD compared with the lowest Xe/CT CBF CVR was 35.5%, specificity and positive predictive values were 100%, and negative predictive value was 66.7%. The index of validity was between 72% and 76%. Conclusions-TCD is much less sensitive than Xe/CT CBF in identifying patients with compromised CVR. This may be a result of the inability of TCD to identify patients with compromised reserves when their MCA blood flow comes from collateral sources. The lack of correlation between TCD and Xe/CT CBF for identifying patients with compromised CVR should be considered when stroke risk assessments are made by TCD.
S tenosis or occlusion of the internal carotid artery is associated with a high rate of a subsequent stroke: Ϸ24% for the first 18 months for high-grade symptomatic stenosis, 6% per year for occlusion, and 33% to 40% per year for those with stenosis on one side and occlusion on the other. [1] [2] [3] In a retrospective study, Webster and colleagues 4 reported a stroke rate of 28.9% in 2 years (21% the first year, unpublished results) in symptomatic patients with carotid stenosis or occlusion and a negative cerebrovascular reserve (CVR) of Ϫ5% or lower determined by xenon-enhanced CT (Xe/CT) cerebral blood flow (CBF) in response to a vasodilatory challenge with acetazolamide. PET has also been used to evaluate patients at risk for stroke. High oxygen extraction fraction, indicating a lack of autoregulation, correlated with a stroke rate of 28% over 31.5 months. 5 Yamauchi et al 6 found that the area of lowest perfusion and highest oxygen extraction fraction has the highest risk for infarction.
Several studies indicate that transcranial Doppler ultrasonography (TCD) can identify patients at increased risk for stroke (Table 1) . Vernieri et al 7 showed that impaired CVR as revealed by TCD with breath holding is predictive of cerebral ischemic events in patients with carotid artery occlusion. Kleiser and Widder 8 reported that with TCD and a CO 2 challenge, patients with exhausted CVR ipsilateral to a stenotic or an occluded carotid artery had a significantly elevated rate of stroke similar to but less than that found with Xe/CT by Webster et al. 4 Silvestrini et al 9 reported that the risk of stroke or transient ischemic events in patients with asymptomatic carotid artery stenosis is related to impaired cerebrovascular reactivity to hypercapnia measured by TCD. Gur et al 10 demonstrated that TCD was useful for evaluating CVRs and identifying patients with a higher risk of transient ischemic attacks (TIAs) or ischemia. Chimowitz et al 11 found an association between compromised reserves and TIA and suggested that TCD with acetazolamide may allow identification of patients who are at higher risk for stroke.
Several studies have compared changes of TCD velocity measurements with changes in CBF obtained with singlephoton emission CT and xenon-133 ( 133 Xe) inhalation. Dahl et al, 12 Piepgras et al, 13 and Bishop et al 14 found a correlation between TCD and 133 Xe CBF measurements. Brauer et al 15 compared CVR measured by TCD and by Xe/CT CBF in 32 patients who had various clinical indications, including subarachnoid hemorrhage, head trauma, and liver failure. The authors speculated that their finding of a lack of correlation between TCD and CBF CVR could be a result of collateral flow, which is included in the Xe/CT CBF results but not assessed by TCD when insonating the middle cerebral artery (MCA). They also stated that the relationship of velocity changes may depend on the underlying diagnosis.
This study examined the relationship between TCD assessment of CVR compared with quantitative Xe/CT CBF. If TCD provides sensitivity, specificity, positive predictive value, negative predictive value, and index of validity equal to that of Xe/CT CBF-measured CVR, this widely available and less expensive technology could be used routinely to identify patients at increased risk for stroke. If the results are different, an understanding of this difference should help to guide the clinical role of each technology in studies of CVR.
Subjects and Methods
Over 4 years, 38 patients, 12 women (32%) and 26 men (68%) 53 to 88 years of age (mean, 71 years), were entered in the study. Informed consent was obtained by the principal investigator from all patients entered. The study was approved by the University of Pittsburgh Institutional Review Board. The patients were diagnosed with internal carotid artery stenosis (Ն70%, 3 patients) or occlusion (34 patients) determined by angiography or CT angiography. One additional patient had occlusion of the left common carotid artery. Of these patients, 20 (53%) had Ն70% stenosis or complete occlusion contralaterally. Twelve additional patients (32%) had between 50% and 70% stenosis contralaterally. All but 4 patients were diagnosed with a TIA or nondisabling stroke. TCD insonation of the MCA could not be performed in 5 patients because of failure to obtain an adequate bone window. In 3 patients, velocities could be obtained from only 1 side. Four patients had Xe/CT CBF and TCD studies both before and after contralateral carotid endarterectomy, and 2 patients had a Xe/CT CBF and TCD study only after contralateral carotid endarterectomy. Seventy-six percent of the patients had hypertensive disease, 16% had diabetes, and 61% had smoked or were still smoking.
Blood Flow Measurements

Xe/CT Method
During Xe/CT CBF studies, patients inhaled through a face mask a 28% concentration of medical-grade Xe gas in 40% oxygen (XeScan stable xenon in oxygen USP, Praxair Pharmaceutical Gases, Praxair, Inc) for 4.3 minutes, during which time rapid sequential CT scanning (General Electric) of 3 or 4 preselected levels (slices) of the brain was performed. Studies covered either 55 or 65 mm of brain tissue. CVRs were assessed by inducing a vasodilatory challenge with 1 g acetazolamide (diamox), a carbonic anhydrase inhibitor 16 injected intravenously after the baseline Xe/CT CBF study. The Xe/CT CBF study was repeated 15 to 20 minutes later. The cerebral tissue acidosis caused by acetazolamide dramatically increases the blood flow to uncompromised territories of the brain by 30% to 40%, whereas territories that are hemodynamically compromised are unchanged presumably because vessels are already maximally dilated. Those that are most severely compromised demonstrate a "steal" phenomenon (ie, a decrease in CBF). 17 The signal-to-noise ratio was Ϸ8:1 when Xe/CT CBF studies were performed. With this amount of signal, reliable, quantitative CBF values have been obtained when regions of interest (ROIs) include Ͼ120 measurements because at that point the measurement error is Ͻ12%. 18 The 2 studies were done only 15 to 20 minutes apart, and the same planes were located and scanned. There were no misregistration effects from the use of separate baseline and acetazolamide studies unless the patient moved during image acquisition. Misregistration could be detected from the confidence images, and ROIs with poor confidence were deleted from the analysis.
TCD Method
The TCD ultrasonography was performed to measure blood velocity in the MCA before the standard Xe/CT scan and within 25 to 55 minutes of administration of acetazolamide. The TCD method used a transtemporal approach permitting insonation of the M1 segment of the MCA. The TCD system (Medasonics) used was a pulsed Doppler that operates at 2 MHz (EME TC 2-64). Cranial depths of 35 to 60 mm were sampled at 5-mm steps. The power output of the transducer was set at 100 mV/cm 2 , allowing for optimal insonation via the transtemporal window. Systolic MCA velocities were used for this analysis.
A normal response in mean TCD values after acetazolamide is an increase of 29 cm/s for women and 21 cm/s for men, 19 which is equivalent to a 49.3% and a 38.9% change, respectively. This ¶Small number of subjects (4 of 7 patients with high OEF had a stroke).
amount of augmentation found with TCD is similar to the amount found with Xe/CT CBF methods in normal subjects. Therefore, the percent change (reserve status) was calculated the same way for the 2 technologies.
Data Analysis
The percent change between baseline and acetazolamide studies in these patients was calculated on the basis of systolic TCD values and the Xe/CT CBF values of the MCA. This constituted the CVR measurement. The formula for calculating percent change for both types of studies was as follows: postacetazolamide (velocity, cm/s) divided by preacetazolamide (velocity, cm/s) minus 1 times 100, and postacetazolamide (CBF, mL · 100 g Ϫ1 · min Ϫ1 )divided by preacetazolamide (CBF, mL · 100 g Ϫ1 · min
Ϫ1
) minus 1 times 100. For the Xe/CT CBF study, cortical flow values were obtained by placement of a series of 6 contiguous 2-cm ROIs (more than Ϸ300 pixels each) within the MCA territory 20 for each of 4 levels (3 levels in 4 patients). Level 1 included the basal ganglia and paralleled the frontal skull base near the orbitomeatal line. Each of the 3 additional levels were cut 1.5 cm above the lowest level. The mean MCA CBF for each level was calculated by summing the values of the ROIs and dividing by the number of ROIs for each level. Results also were analyzed by averaging the percent change for all ROIs of all levels of the MCA territory. For each Xe/CT study, the CT scan was analyzed separately for alterations consistent with stroke, and individual ROIs showing infarction were deleted from the analysis. If an MCA territory Ͼ3 ROIs (ie, Ͼ50% infarction) with densities indicating infarction, the whole territory for that level was eliminated from the analysis.
Sensitivity, specificity, positive predictive value, negative predictive value, and an index of validity were calculated for comparison of the TCD and the Xe/CT CBF CVRs. The formula for the index of validity was true positives plus true negatives divided by the total number of cases. 21 Cohen's statistic was used as a chancecorrected measure of agreement between the 2 methods. For the analysis, the results of each patient's blood flow were classified into 1 of 2 groups (Ն0, Ͻ0). To take into account the continuous nature of the data, Spearman correlations were also calculated.
Results
The sensitivity and specificity of the TCD velocity changes compared with the Xe/CT CBF CVR data were calculated different ways: (1) the MCA territory with the lowest percent change for the Xe/CT CBF or the average over 4 levels of the MCA territory for the Xe/CT CBF, and (2) all data, including both sides, only the occluded side, and only the contralateral side ( Table 2 ). The greatest sensitivity was found for the ipsilateral data with the lowest MCA analysis (43%). The lowest sensitivity was found with the analysis of the lowest MCA values for the contralateral side (20%). The sensitivity for all data (both sides) was 33% for the average MCA calculation and 35.5% for the lowest MCA calculation. Although the sensitivity of CVR for TCD compared with the Xe/CT CBF method was marginal, the specificities were relatively high, indicating that there was agreement between the 2 methods for the true negatives (patients correctly identified as negative for compromised reserves, ie, positive reserves). The index of validity was 71% for the lowest MCA analyses and 76% for the average MCA analyses.
A subanalysis of the marginal reserves (between Ϫ5 and 5) and the positive reserves (Ͼ5) showed that the sensitivity was low for TCD compared with Xe/CT CBF (22% for the lowest MCA calculation of Xe/CT CBF values and 16.6% for average values; Table 2 ).
For the Cohen's analysis, the patients were separated into the following 2 groups on the basis of their percent change in Xe/CT CBF values: positive reserves Ͼ0% and compromised reserves Ͻ0%. The Cohen's analysis showed comparatively low agreement between the TCD and Xe/CT CBF CVR measurements (ϭ0.38 for the lowest MCA level, Table 3 ; 0.27 for the averaged MCA levels, Table 3 ). Figure 1 shows the Xe/CT CBF results for a patient who had right symptomatic internal carotid artery occlusion and 50% contralateral carotid stenosis. Two Xe/CT CBF studies (baseline and acetazolamide) are included, each showing 4 different levels through the brain. It was determined that this patient's blood flow did not augment in the right MCA of levels 2, 3, and 4 after acetazolamide in the Xe/CT CBF study but did augment in the TCD study.
A graph of the CVR (Figures 2 and 3) shows that most patients who had positive reserves by Xe/CT CBF also had positive reserves by TCD. More important, it also shows that there were patients who had negative reserves by the Xe/CT CBF method and positive reserves by TCD (false negatives). There were 12 data points in this category for the averaged data ( Figure 2 ) and 20 data points for the lowest MCA territory data (Figure 3) . Lowest MCA indicates that the calculations were based on the MCA territory that had the lowest Xe/CT CBF value; Average MCA, calculations were based on the average of all 4 levels for the MCA territory for the Xe/CT CBF data; PPV, positive predictive value; NPV, negative predictive value; and both, all of the data-ipsilateral (Ipsil) and contralateral (contral) hemispheres combined.
A Spearman correlation test revealed that there is a moderate correlation between CVR measured by the 2 tests. The Spearman correlation estimate was 0.35 (Pϭ0.003) for the lowest category and 0.32 (Pϭ0.007) for the average Xe/CT CBF category when the hypothesis that TCD and Xe/CT CBF tests were independent was tested.
Discussion
We have compared CVR assessed with both TCD and quantitative CBF to understand how differences between these technologies may affect the identification of patients with compromised reserves who may be at increased risk for stroke. The primary result of this study is that changes in velocity measured within the initial portion of the MCA do not reliably predict the changes in tissue perfusion that accompany a vasodilatory stress induced by intravenous acetazolamide. The negative predictive value of TCD is lower if the single level of the brain with the most severe compromise of CVR rather than the average flow change in all levels is compared with MCA velocity changes. A lack of sensitivity to a negative CBF response can be explained in part by the observation that this type of flow response is statistically associated with the absence of blood supply via the circle of Willis and instead a dependence on pial and retrograde ophthalmic collaterals. 22 Thus, it does not seem physiologically reasonable to expect that the rate of blood movement within the trunk MCA should be able to reflect changes in CBF when the MCA is not the primary route of blood supply to the MCA territory. The use of a tomographic high-resolution CBF study appears physiologically sound because it provides the ability to assess flow changes not only within an entire vascular territory but also within the cortical or subcortical regions on each of the levels of study. From the perspective of predicting subsequent ischemic events, only the most severely compromised level that was consistently a level above the basal ganglia was predictive of individuals at increased stroke risk. 4, 17 Quantitative CBF studies have also shown that the most dramatic flow changes in patients with chronic occlusive vascular disease are within the periventricular white matter that is the region most prone to infarction in low-flow states and is clinically associated with symptoms of ischemic claudication. 23 This higher resolution to especially low flow within subcortical structures may help explain why Brauer et al, 15 who used stable Xe/CT CBF, may have had conclusions similar to those of our study, which were different from those of Dahl et al 12 and Piepgras et al, 13 who used either qualitative CBF or regional CBF that has little to no perception of flow changes within subcortical structures.
Although the measurement of oxygen extraction with PET is a useful tool for identification of patients at increased ischemic risk, studies that involve a physiological stress and the repeated measurement of a single flow-related variable also have this capacity. 24, 25 By changing only 1 variable, a flow-related stress test examines only the ability of the circulation to respond to a well-understood and predictable physiological stress. Whether a rise in local tissue hydrogen ions is induced by an increase in the level of PCO 2 or by intravenous injection of acetazolamide, the result is the same. This type of challenge can only induce dilatation, and if no elevation in CBF is observed, one can only assume that the vascular bed in question is already maximally vasodilated. 24, 25 A maximal CBV is integral to the state of severe hemodynamic compromise reported by Grubb et al 5 and is associated with a rise in oxygen extraction. Nariai et al 26 have reported a correlation between elevated oxygen extraction fraction and decreased Xe/CT CBF in patients with carotid occlusion. It has been our preference to use acetazolamide because it is well tolerated at a dose of about 17 mg/kg (about 1 g for an adult) and it produces a reliable significant physiological challenge. Although a CO 2 challenge is theoretically simpler to induce by breath holding or the inhalation of 3% to 5% CO 2 , the resulting PCO 2 change is very unpredictable and is often associated with anxiety and hypertension, thus confounding the interpretation of CBF data. 27 Consideration must be given to the potential design problems of the study. The time of the TCD study was between 40 and 70 minutes after acetazolamide administration, whereas the second Xe/CT CBF study was done 20 minutes afterward. Considering that after 90 minutes half of the acetazolamide is still active, we are within the limits for observing an increase in vasoreactivity. 28 The second potential problem is that we did not measure CO 2 during the time the TCD studies were performed. Although CO 2 probably decreased during this study because of an increased respiratory rate, the acidification of cerebrospinal fluid by acetazolamide persists despite the counteracting effect of the relative hypocapnia. Consideration must be given to the potential problems of using TCD, such as the inability to obtain TCD values in Ϸ5% to 15% of patients 8, 29, 30 and the operator dependence of the TCD measurements. A potential problem of Xe/CT CBF is the belief that Xe increases blood flow, but this is not significant until 5 minutes of inhalation, which is longer than the 4.3 minutes used in this study. Modeling has provided further support by confirming a minimal effect of Xe inhalation on the calculated versus "real" CBF values using the currently employed method for calculated CBF. 31 Xe also has an effect on the sensorium, but with the reduction in Xe from 33% to 28%, there has been a significant reduction in even minimal symptoms.
TCD velocity changes by acetazolamide have been shown to be insensitive to areas of negative reactivity compared with quantitative CBF and therefore may not be the optimum method for assessing cerebral hemodynamic compromise in patients with carotid occlusive disease. Further studies are needed to determine whether CVRs measured by TCD or quantitative or qualitative CBF or oxygen extraction fraction measured by PET are comparable in predicting risk for stroke.
